251 related articles for article (PubMed ID: 7723207)
1. Immunosuppressive acidic protein in intraocular fluids.
Takeda Y; Yamaguchi K; Tamai M
Jpn J Ophthalmol; 1994; 38(4):388-91. PubMed ID: 7723207
[TBL] [Abstract][Full Text] [Related]
2. Low mature TGF-beta 2 levels in aqueous humor during uveitis.
de Boer JH; Limpens J; Orengo-Nania S; de Jong PT; La Heij E; Kijlstra A
Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3702-10. PubMed ID: 7522227
[TBL] [Abstract][Full Text] [Related]
3. High levels of interleukin-12 in the aqueous humor and vitreous of patients with uveitis.
el-Shabrawi Y; Livir-Rallatos C; Christen W; Baltatzis S; Foster CS
Ophthalmology; 1998 Sep; 105(9):1659-63. PubMed ID: 9754174
[TBL] [Abstract][Full Text] [Related]
4. Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis.
Ongkosuwito JV; Feron EJ; van Doornik CE; Van der Lelij A; Hoyng CB; La Heij EC; Kijlstra A
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2659-65. PubMed ID: 9856775
[TBL] [Abstract][Full Text] [Related]
5. [Angiogenesis factor in intraocular tumors].
Barraquer RI; Domenech Mateu JM; Fernández Cotero JN; Muiños Muro SJ; Iglesias Touriño E
Rev Esp Oncol; 1982; 29(3):413-21. PubMed ID: 6084270
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic pars plana vitrectomy and aqueous analyses in patients with uveitis of unknown cause.
Oahalou A; Schellekens PA; de Groot-Mijnes JD; Rothova A
Retina; 2014 Jan; 34(1):108-14. PubMed ID: 23619637
[TBL] [Abstract][Full Text] [Related]
7. Preparation and cytologic evaluation of intraocular fluids.
Mandell DB; Levy JJ; Rosenthal DL
Acta Cytol; 1987; 31(2):150-8. PubMed ID: 3493610
[TBL] [Abstract][Full Text] [Related]
8. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
9. [The immunosuppressive acidic protein in the vitreous of fundus diseases].
Takeda Y; Yamaguchi K; Ishiguro S; Tamura K; Tamai M
Nippon Ganka Gakkai Zasshi; 1992 Apr; 96(4):506-10. PubMed ID: 1621592
[TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
11. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
12. Association between aqueous humor and vitreous fluid levels of Th17 cell-related cytokines in patients with proliferative diabetic retinopathy.
Takeuchi M; Sato T; Sakurai Y; Taguchi M; Harimoto K; Karasawa Y; Ito M
PLoS One; 2017; 12(5):e0178230. PubMed ID: 28558009
[TBL] [Abstract][Full Text] [Related]
13. Combined extracapsular cataract extraction, posterior chamber intraocular lens implantation, and pars plana vitrectomy.
Foster RE; Lowder CY; Meisler DM; Zakov ZN; Meyers SM; Ambler JS
Ophthalmic Surg; 1993 Jul; 24(7):446-52. PubMed ID: 8351090
[TBL] [Abstract][Full Text] [Related]
14. Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF).
Nicoletti VG; Nicoletti R; Ferrara N; Meli G; Reibaldi M; Reibaldi A
Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):209-14. PubMed ID: 12845559
[TBL] [Abstract][Full Text] [Related]
15. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
16. The role of soluble TNF receptors for TNF-alpha in uveitis.
Sugita S; Takase H; Taguchi C; Mochizuki M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3246-52. PubMed ID: 17591895
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor in ocular fluids of patients with uveitis.
Taguchi C; Sugita S; Tagawa Y; Nishihira J; Mochizuki M
Br J Ophthalmol; 2001 Nov; 85(11):1367-71. PubMed ID: 11673308
[TBL] [Abstract][Full Text] [Related]
18. Changes in vitreous concentrations of human hepatocyte growth factor (hHGF) in proliferative diabetic retinopathy: implications for intraocular hHGF production.
Nishimura M; Ikeda T; Ushiyama M; Kinoshita S; Yoshimura M
Clin Sci (Lond); 2000 Jan; 98(1):9-14. PubMed ID: 10600653
[TBL] [Abstract][Full Text] [Related]
19. [Glutamate concentration in diabetic vitreous].
Asensio Sánchez VM; Corral Azor A; Aguirre Aragón B; De Paz García M
Arch Soc Esp Oftalmol; 2003 Sep; 78(9):493-7. PubMed ID: 14517736
[TBL] [Abstract][Full Text] [Related]
20. Intraocular and plasma levels of cellular fibronectin in patients with uveitis and diabetes mellitus.
Probst K; Fijnheer R; Schellekens P; Rothova A
Br J Ophthalmol; 2004 May; 88(5):667-72. PubMed ID: 15090421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
